Descrizione del progetto
Promuovere il campo dei coniugati farmacologici proteici
L’Istituto portoghese di medicina molecolare (IMM) riceverà una spinta scientifica nel suo lavoro sulla ricerca sul genoma umano e sullo sviluppo di nuovi approcci terapeutici. Il progetto SIMICA, finanziato dall’UE, integrerà l’IMM nella cerchia europea delle istituzioni di eccellenza della ricerca attraverso una rete sostenibile di scienza, tecnologia e innovazione comprendente organizzazioni leader a livello internazionale nel campo dei coniugati proteici. La strategia di SIMICA si basa sull’agglomerazione guidata dalla scienza e dall’innovazione. Si concentrerà sulla progettazione e costruzione della prossima generazione di coniugati proteici chimicamente definiti e innovativi per il trattamento mirato di condizioni gravi quali il cancro. Offrirà inoltre opportunità di formazione e mentoraggio ai giovani ricercatori IMM.
Obiettivo
SIMICA will provide IMM with the opportunity to integrate the European circle of research excellence institutions by cementing a sustainable science, technology and innovation network with internationally-leading organisations in the field of protein drug-conjugates. The strategy of SIMICA is based on science- and innovation-driven clustering, and is focused on the exciting and upcoming area of designing and constructing the next generation of chemically-defined and innovative protein drug-conjugates for the targeted treatment of serious conditions such as cancer. The project will allow: i) strengthening the science and technology capacity of IMM and ii) leverage its research excellence and value creation through innovation with a beneficial and quantifiable impact for the entire research and development community at IMM, the Lisbon region and Portugal. The successful implementation of this strategy will rely on specific actions, including: 1) cementing of existing and the creation of new scientific, innovative and technical collaborations through short-term staff exchanges and short-term on-site training activities; 2) training, mentoring and international exposure of IMMs young researchers and students; 3) building an innovation ecosystem centred at IMM; 4) igniting the entrepreneurial spirit among IMMs research community; 5) increasing science awareness among the general public through targeted dissemination and communication activities; and 6) developing a sustainability strategy to sustain the cemented network beyond project terminus. Through the completion of these activities, IMM, supported by its twinning partners, is in the best temporal and spatial position to achieve an improved capability to compete for internationally competitive research funding and to access business stakeholders. By claiming its position in research and innovation networks IMM will effectively contribute to research excellence and value creation in health at European level.
Parole chiave
Programma(i)
- H2020-EU.4.b. - Twinning of research institutions Main Programme
Argomento(i)
Invito a presentare proposte
(si apre in una nuova finestra) H2020-WIDESPREAD-2018-2020
Vedi altri progetti per questo bandoBando secondario
H2020-WIDESPREAD-2018-03
Meccanismo di finanziamento
CSA -Coordinatore
1649-035 LISBOA
Portogallo